Overview

Safety, Tolerability and Pharmacokinetics of SAR113945 Following Intra-articular Administration in Patients With Knee Osteoarthritis

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Primary Objective: - Assess the safety and tolerability of single intra-articular doses of SAR113945 in patients with knee osteoarthritis. Secondary Objective: - Assess systemic exposure of SAR113945 following intra-articular delivery.
Phase:
Phase 1
Details
Lead Sponsor:
Sanofi